Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Sunshine Biopharma (SBFM) over the last 13 years, with Q3 2025 value amounting to -$36168.0.

  • Sunshine Biopharma's Other Working Capital Changes rose 5680.66% to -$36168.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $166842.0, marking a year-over-year increase of 84106.83%. This contributed to the annual value of $207167.0 for FY2024, which is 87983.73% up from last year.
  • Latest data reveals that Sunshine Biopharma reported Other Working Capital Changes of -$36168.0 as of Q3 2025, which was up 5680.66% from -$115617.0 recorded in Q2 2025.
  • Sunshine Biopharma's 5-year Other Working Capital Changes high stood at $568981.0 for Q1 2024, and its period low was -$736637.0 during Q2 2024.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$21172.0 (2022), whereas its average is -$6284.5.
  • As far as peak fluctuations go, Sunshine Biopharma's Other Working Capital Changes surged by 114848.02% in 2021, and later crashed by 186044.99% in 2022.
  • Sunshine Biopharma's Other Working Capital Changes (Quarter) stood at $4579.0 in 2021, then crashed by 1860.45% to -$80611.0 in 2022, then surged by 433.85% to $269120.0 in 2023, then skyrocketed by 70.39% to $458558.0 in 2024, then crashed by 107.89% to -$36168.0 in 2025.
  • Its Other Working Capital Changes stands at -$36168.0 for Q3 2025, versus -$115617.0 for Q2 2025 and -$139931.0 for Q1 2025.